ERBITUX SOLN FOR INF /ML: 55 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
55
Total FAERS Reports
18 (32.7%)
Deaths Reported
24
Hospitalizations
55
As Primary/Secondary Suspect
11
Life-Threatening
6
Disabilities
First Report: 20120501 · Latest Report: 20140611
What Are the Most Common ERBITUX SOLN FOR INF /ML Side Effects?
#1 Most Reported
Interstitial lung disease
6 reports (10.9%)
#2 Most Reported
Dermatitis acneiform
6 reports (10.9%)
#3 Most Reported
Decreased appetite
6 reports (10.9%)
All ERBITUX SOLN FOR INF /ML Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Decreased appetite | 6 | 10.9% | 2 | 1 |
| Dermatitis acneiform | 6 | 10.9% | 2 | 2 |
| Interstitial lung disease | 6 | 10.9% | 6 | 1 |
| Febrile neutropenia | 5 | 9.1% | 1 | 2 |
Who Reports ERBITUX SOLN FOR INF /ML Side Effects? Age & Gender Data
Average age: 66.5 years. Most reports from: DE. View detailed demographics →
Is ERBITUX SOLN FOR INF /ML Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 2 | 0 | 0 |
| 2013 | 30 | 13 | 15 |
| 2014 | 18 | 4 | 8 |
What Is ERBITUX SOLN FOR INF /ML Used For?
| Indication | Reports |
|---|---|
| Colon cancer | 11 |
| Head and neck cancer | 6 |
| Hypopharyngeal cancer | 6 |
| Colorectal cancer | 5 |
Official FDA Label for ERBITUX SOLN FOR INF /ML
Official prescribing information from the FDA-approved drug label.